Document is current
Any future updates will be listed below
-
Authors
Leman, Raphaël
Cherifi, François
Leheurteur, Marianne
Theret, Pierrick
Pasquesoone, Camille
Saint-Ghislain, Mathilde
Bresson, Lucie
Denoyelle, Christophe
Vigneron, Nicolas
Poulain, Laurent
Delepee, Raphaël
Berby, Benoit
Dremaux, Julie
Dumont, Aurélie
Blanc-Fournier, Cécile
Jeanne, Corinne
Briand, Mélanie
Rousseau, Nathalie
Pepin, Louis-Ferdinand
Deruche, Elodie
Dumont, Fabienne
Leconte, Alexandra
Lequesne, Justine
Clarisse, Bénédicte
Joly, Florence
Castera, Laurent
Rouzier, Roman
-
Funding
Funding for this research was provided by:
French Health Ministry through North West interregional hospital clinical research program (PHRCI-2022-72)
- License Information
-
More Information
Article History
Received: 22 May 2025
Accepted: 30 May 2025
First Online: 1 July 2025
Declarations
:
: This study has received ethical approval from the Comité de Protection des Personnes Ile de France IV in November 2023 (N° IDRCB 2023-A01585-40, Ref 23.03705.000286). All patients will be proposed to participate by medical oncologists, who will give them an information file. All patients will give their written informed consent before any study-related assessment start. This study will be performed in accordance with the relevant guidelines and regulations (Declaration of Helsinki).
: Not applicable.
: The authors declare no competing interests.
